Serum resistin level in obstructive sleep apnea patients complicated with cardiac diseases, diabetes mellitus or renal impairment

Background: Obstructive sleep apnea (OSA) has been independently associated with cardiovascular diseases, including hypertension, coronary heart disease and heart failure. Also, it had a deleterious impact on renal function and a link to diabetes mellitus (DM) and insulin resistance. Resistin is new...

Full description

Bibliographic Details
Main Authors: Basem I. El-Shafey, Mohammad M. El-Bedewy, Tymor Mostafa, Mohmad Attia
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0422763814200653
_version_ 1828316596458749952
author Basem I. El-Shafey
Mohammad M. El-Bedewy
Tymor Mostafa
Mohmad Attia
author_facet Basem I. El-Shafey
Mohammad M. El-Bedewy
Tymor Mostafa
Mohmad Attia
author_sort Basem I. El-Shafey
collection DOAJ
description Background: Obstructive sleep apnea (OSA) has been independently associated with cardiovascular diseases, including hypertension, coronary heart disease and heart failure. Also, it had a deleterious impact on renal function and a link to diabetes mellitus (DM) and insulin resistance. Resistin is new adipokine and may play a role in cardiac, diabetics and renal patients. Aim of the work: The aim of this work is screening of cardiac dysfunction, DM and renal impairment in OSA patients and to study the role of resistin serum level in occurrence of these complications. Subjects and methods: This study was carried out on 10 control persons (group I) and 143 patients with OSA (group II). The following were done to all persons: body mass index (BMI), blood pressure measurement, fasting and post prandial blood sugar levels, serum creatinine and ECG, diagnostic sleep study, echocardiogram, estimated glomerular filtration rate (eGFR) and serum resistin assay. According to the above results, group II was divided into 4 subgroups, A (33OSAS patients), B (21 OSAS patients with cardiac troubles), C (40 OSAS patients with DM) and D (13 OSAS patients with renal impairment). 36 OSAS patients were excluded from the study because they had either 2 or more of the above abnormalities (cardiac, DM and renal). Results: There was significant increase of ESS and plasma resistin level in subgroups IIB, IIC and IID as compared group I and subgroup IIA which was significantly increased as compared to group I. There was no significant difference of BMI in subgroups IIA, IIB, IIC and IID but SaO2 and AHI were significantly increased in subgroups IIB, IIC and IID as compared to IIA. In group II, there was a significant positive correlation between plasma resistin level and AHI, SaO2 but there was no significant correlation between BMI and plasma resistin level. Conclusion: OSA patients can be complicated with cardiac diseases, DM and renal impairment through elevated resistin serum levels. Recommendation: Effect of CPAP on resistin serum level must be evaluated in these patients.
first_indexed 2024-04-13T17:16:59Z
format Article
id doaj.art-c9465133babd4f8ebff0cbc232000763
institution Directory Open Access Journal
issn 0422-7638
language English
last_indexed 2024-04-13T17:16:59Z
publishDate 2015-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Egyptian Journal of Chest Disease and Tuberculosis
spelling doaj.art-c9465133babd4f8ebff0cbc2320007632022-12-22T02:38:07ZengWolters Kluwer Medknow PublicationsEgyptian Journal of Chest Disease and Tuberculosis0422-76382015-01-0164112913510.1016/j.ejcdt.2014.12.002Serum resistin level in obstructive sleep apnea patients complicated with cardiac diseases, diabetes mellitus or renal impairmentBasem I. El-Shafey0Mohammad M. El-Bedewy1Tymor Mostafa2Mohmad Attia3Chest Department, Tanta University, EgyptGeneral Medicine Department, Tanta University, EgyptCardiology Department, Tanta University, EgyptClinical Pathology Department, Tanta University, EgyptBackground: Obstructive sleep apnea (OSA) has been independently associated with cardiovascular diseases, including hypertension, coronary heart disease and heart failure. Also, it had a deleterious impact on renal function and a link to diabetes mellitus (DM) and insulin resistance. Resistin is new adipokine and may play a role in cardiac, diabetics and renal patients. Aim of the work: The aim of this work is screening of cardiac dysfunction, DM and renal impairment in OSA patients and to study the role of resistin serum level in occurrence of these complications. Subjects and methods: This study was carried out on 10 control persons (group I) and 143 patients with OSA (group II). The following were done to all persons: body mass index (BMI), blood pressure measurement, fasting and post prandial blood sugar levels, serum creatinine and ECG, diagnostic sleep study, echocardiogram, estimated glomerular filtration rate (eGFR) and serum resistin assay. According to the above results, group II was divided into 4 subgroups, A (33OSAS patients), B (21 OSAS patients with cardiac troubles), C (40 OSAS patients with DM) and D (13 OSAS patients with renal impairment). 36 OSAS patients were excluded from the study because they had either 2 or more of the above abnormalities (cardiac, DM and renal). Results: There was significant increase of ESS and plasma resistin level in subgroups IIB, IIC and IID as compared group I and subgroup IIA which was significantly increased as compared to group I. There was no significant difference of BMI in subgroups IIA, IIB, IIC and IID but SaO2 and AHI were significantly increased in subgroups IIB, IIC and IID as compared to IIA. In group II, there was a significant positive correlation between plasma resistin level and AHI, SaO2 but there was no significant correlation between BMI and plasma resistin level. Conclusion: OSA patients can be complicated with cardiac diseases, DM and renal impairment through elevated resistin serum levels. Recommendation: Effect of CPAP on resistin serum level must be evaluated in these patients.http://www.sciencedirect.com/science/article/pii/S0422763814200653OSACardiacDMRenalComplicationResistin
spellingShingle Basem I. El-Shafey
Mohammad M. El-Bedewy
Tymor Mostafa
Mohmad Attia
Serum resistin level in obstructive sleep apnea patients complicated with cardiac diseases, diabetes mellitus or renal impairment
Egyptian Journal of Chest Disease and Tuberculosis
OSA
Cardiac
DM
Renal
Complication
Resistin
title Serum resistin level in obstructive sleep apnea patients complicated with cardiac diseases, diabetes mellitus or renal impairment
title_full Serum resistin level in obstructive sleep apnea patients complicated with cardiac diseases, diabetes mellitus or renal impairment
title_fullStr Serum resistin level in obstructive sleep apnea patients complicated with cardiac diseases, diabetes mellitus or renal impairment
title_full_unstemmed Serum resistin level in obstructive sleep apnea patients complicated with cardiac diseases, diabetes mellitus or renal impairment
title_short Serum resistin level in obstructive sleep apnea patients complicated with cardiac diseases, diabetes mellitus or renal impairment
title_sort serum resistin level in obstructive sleep apnea patients complicated with cardiac diseases diabetes mellitus or renal impairment
topic OSA
Cardiac
DM
Renal
Complication
Resistin
url http://www.sciencedirect.com/science/article/pii/S0422763814200653
work_keys_str_mv AT basemielshafey serumresistinlevelinobstructivesleepapneapatientscomplicatedwithcardiacdiseasesdiabetesmellitusorrenalimpairment
AT mohammadmelbedewy serumresistinlevelinobstructivesleepapneapatientscomplicatedwithcardiacdiseasesdiabetesmellitusorrenalimpairment
AT tymormostafa serumresistinlevelinobstructivesleepapneapatientscomplicatedwithcardiacdiseasesdiabetesmellitusorrenalimpairment
AT mohmadattia serumresistinlevelinobstructivesleepapneapatientscomplicatedwithcardiacdiseasesdiabetesmellitusorrenalimpairment